{"id":"https://openalex.org/W2078135089","doi":"https://doi.org/10.1158/1538-7445.am2013-1019","title":"Abstract 1019: Cytotoxicity in vitro, pharmacokinetics and tissue distribution of Link-N3 and Link-F3, two bivalent small molecules inhibitors of c-Myc/Max interactions in C.B-17 SCID mice bearing Daudi Burkitt's lymphoma xenografts.","display_name":"Abstract 1019: Cytotoxicity in vitro, pharmacokinetics and tissue distribution of Link-N3 and Link-F3, two bivalent small molecules inhibitors of c-Myc/Max interactions in C.B-17 SCID mice bearing Daudi Burkitt's lymphoma xenografts.","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2078135089","doi":"https://doi.org/10.1158/1538-7445.am2013-1019","mag":"2078135089"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2013-1019","doi":"https://doi.org/10.1158/1538-7445.am2013-1019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-1019","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070200212","display_name":"Jianxia Guo","orcid":"https://orcid.org/0000-0002-2732-8220","observed_orcids":["https://orcid.org/0000-0002-2732-8220"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jianxia Guo","raw_affiliation_strings":["1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075041951","display_name":"Dana M. Clausen","orcid":"https://orcid.org/0000-0001-7482-7041","observed_orcids":["https://orcid.org/0000-0001-7482-7041"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana M. Clausen","raw_affiliation_strings":["1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086726605","display_name":"Edward V. Prochownik","orcid":"https://orcid.org/0000-0001-9666-8205","observed_orcids":["https://orcid.org/0000-0001-9666-8205"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward V. Prochownik","raw_affiliation_strings":["1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047748993","display_name":"Steven J. Metallo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven J. Metallo","raw_affiliation_strings":["2Georgetown University/Dept. of Chemistry, Washington, DC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Georgetown University/Dept. of Chemistry, Washington, DC","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077511890","display_name":"Robert A. Parise","orcid":"https://orcid.org/0000-0003-4398-6271","observed_orcids":["https://orcid.org/0000-0003-4398-6271"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A. Parise","raw_affiliation_strings":["1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027371881","display_name":"Jan Hendrik Beumer","orcid":"https://orcid.org/0000-0002-8978-9401","observed_orcids":["https://orcid.org/0000-0002-8978-9401"]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan H. Beumer","raw_affiliation_strings":["1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108198888","display_name":"Julie L. Eiseman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128526","display_name":"UPMC Hillman Cancer Center","ror":"https://ror.org/03bw34a45","country_code":"US","type":"facility","lineage":["https://openalex.org/I170201317","https://openalex.org/I4210128526"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie L. Eiseman","raw_affiliation_strings":["1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA;","institution_ids":["https://openalex.org/I4210128526"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"73","issue":"8_Supplement","first_page":"1019","last_page":"1019"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.5752000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.5752000212669373,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.07540000230073929,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.03999999910593033,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/10058-f4","display_name":"10058-F4","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7139999866485596},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-metabolism","display_name":"drug metabolism","score":0.7239999771118164},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7210000157356262},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6639999747276306},{"id":"https://openalex.org/keywords/xenografts","display_name":"xenografts","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5271677374839783},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.515061616897583},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.495354562997818},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4907906949520111},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4691407084465027},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.46728405356407166},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.4531736969947815},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.42218703031539917},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38830721378326416},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37909844517707825},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.373291552066803},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.281144380569458},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2593334913253784},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.08886906504631042}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2013-1019","doi":"https://doi.org/10.1158/1538-7445.am2013-1019","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2013-1019","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8999999761581421,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1976704088","https://openalex.org/W2141200011","https://openalex.org/W2018587390","https://openalex.org/W2035250214","https://openalex.org/W4281572042","https://openalex.org/W2095541308","https://openalex.org/W2094619972","https://openalex.org/W2094332231","https://openalex.org/W2319510522","https://openalex.org/W3082134004"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"c-Myc":[2,35,56,67],"plays":[3],"an":[4],"important":[5],"role":[6],"in":[7,26,94,113,268,391,408,444,462],"cellular":[8],"proliferation,":[9],"differentiation,":[10],"apoptosis":[11],"and":[12,16,23,54,60,80,111,126,141,152,160,180,186,194,200,206,227,248,251,260,297,305,310,318,322,334,339,345,350,365,419,447,452],"cell":[13,101,122],"cycle":[14],"progression":[15],"its":[17,39,43],"overexpression":[18],"is":[19,394],"associated":[20],"with":[21,42,147,171,254],"aggressiveness":[22],"poor":[24],"prognosis":[25],"many":[27],"cancers.":[28],"In":[29],"order":[30],"to":[31,77,91,396,412],"be":[32,234,406],"transcriptionally":[33],"active,":[34],"must":[36],"heterodimerize":[37],"via":[38],"bHLH-ZIP":[40],"domain":[41],"obligatory":[44],"partner":[45],"Max.":[46],"Two":[47],"small":[48,65,456],"molecules":[49,457],"that":[50,400],"prevent":[51],"c-Myc/Max":[52,460],"heterodimerization":[53],"inhibit":[55,92],"function":[57],"are":[58],"10074-G5":[59],"10058-F4.":[61],"Analogues":[62],"of":[63,87,97,120,136,139,150,198,263,280,316,328,357,383,387,450,459,474,479],"these":[64,88,409],"molecule":[66],"inhibitors":[68,458],"have":[69,83],"been":[70],"linked":[71],"together":[72],"by":[73,124,130,143,156,204,210],"a":[74,98,276],"flexible":[75],"bridge":[76],"form":[78],"Link-N3":[79,125,140,151,174,199,226,247,283,304,317,338,344,358,388,451],"Link-F3.":[81],"We":[82,106],"characterized":[84],"the":[85,93,219,397,402,475,480],"ability":[86],"Link":[89],"analogues":[90],"vitro":[95],"growth":[96,123,270],"c-Myc-overexpressing":[99],"human":[100],"line,":[102],"Daudi":[103,116,121,144,167,230,244,467],"Burkitt's":[104,468],"lymphoma.":[105],"evaluated":[107],"their":[108],"pharmacokinetics,":[109],"metabolism":[110],"efficacy":[112,213],"mice":[114,165,393,465],"bearing":[115,166,466],"xenografts.":[117,403,470],"Methods:":[118],"Inhibition":[119],"Link-F3":[127,142,153,177,201,228,249,306,319,346,366,390],"was":[128,154,190,330,362,370],"assessed":[129],"MTT":[131],"assay":[132],"after":[133],"72":[134],"h":[135,262],"incubation.":[137,264],"Accumulation":[138],"cells":[145,231,245],"incubated":[146],"10":[148,172,281],"\u03bcM":[149],"measured":[155],"HPLC.":[157],"For":[158,212],"pharmacokinetic":[159],"metabolic":[161],"studies,":[162],"C.B-17":[163,463],"SCID":[164,464],"xenografts":[168],"were":[169,182,202,208,215,294,307,320,347],"treated":[170],"mg/kg":[173,282,286],"or":[175,284,389],"5mg/kg":[176],"IV.":[178],"Plasma":[179,301,314],"tissues":[181],"collected":[183,191],"between":[184,258],"5":[185,285,292,368],"1440":[187,195],"min.":[188,196],"Urine":[189],"at":[192,218,239,291,359,367],"360":[193],"Concentrations":[197],"determined":[203,235],"HPLC-UV,":[205],"metabolites":[207],"identified":[209],"LC-MS/MS.":[211],"compounds":[214,237,411],"administered":[216],"qdx4":[217],"same":[220],"doses.":[221],"Results:":[222],"The":[223,326,381],"IC50\u2019s":[224],"for":[225,303,337,343,483],"against":[229],"could":[232],"not":[233],"because":[236],"precipitated":[238],"concentrations":[240,257,290,399],"above":[241],"30":[242,360],"\u03bcM.":[243],"accumulated":[246],"\u223c19-fold":[250],"\u223c17-fold,":[252],"respectively,":[253],"peak":[255,288,377],"intracellular":[256],"3":[259],"6":[261],"Neither":[265],"compound":[266],"resulted":[267],"tumor":[269,355],"inhibition":[271],"following":[272],"IV":[273,278],"dosing.":[274],"Following":[275],"single":[277],"dose":[279],"Link-F3,":[287,340,453],"plasma":[289,378],"min":[293,361,369],"27.3":[295],"\u03bcg/ml":[296],"5.3":[298],"\u03bcg/ml,":[299],"respectively.":[300,313,325,341,353],"Auc0-t":[302],"1759.6":[308],"\u03bcg\u00b7min/ml":[309],"137.9":[311],"\u03bcg\u00b7min/ml,":[312],"T1/2":[315],"394":[321],"7":[323],"min,":[324],"volume":[327],"distribution":[329,449],"approximately":[331],"3204":[332],"ml/kg":[333,336],"35":[335],"Clearances":[342],"5.6":[348],"ml/min/kg":[349],"3.6":[351],"ml/min/kg,":[352],"Peak":[354],"concentration":[356],"0.77":[363],"\u03bcg/g":[364],"0.49":[371],"\u03bcg/g,":[372],"both":[373],"much":[374],"lower":[375],"than":[376],"concentrations.":[379],"Conclusion:":[380],"lack":[382],"significant":[384],"antitumor":[385],"activity":[386],"tumor-bearing":[392],"related":[395],"low":[398],"reached":[401],"Modification":[404],"will":[405],"required":[407],"bivalent":[410,455],"make":[413],"them":[414],"more":[415],"drug-like.":[416],"Support:":[417],"1R01CA142580":[418],"P30-CA47904":[420],"Citation":[421],"Format:":[422],"Jianxia":[423],"Guo,":[424],"Dana":[425],"M.":[426],"Clausen,":[427],"Edward":[428],"V.":[429],"Prochownik,":[430],"Steven":[431],"J.":[432],"Metallo,":[433],"Robert":[434],"A.":[435],"Parise,":[436],"Jan":[437],"H.":[438],"Beumer,":[439],"Julie":[440],"L.":[441],"Eiseman.":[442],"Cytotoxicity":[443],"vitro,":[445],"pharmacokinetics":[446],"tissue":[448],"two":[454],"interactions":[461],"lymphoma":[469],"[abstract].":[471],"In:":[472],"Proceedings":[473],"104th":[476],"Annual":[477],"Meeting":[478],"American":[481],"Association":[482],"Cancer":[484,494],"Research;":[485],"2013":[486],"Apr":[487],"6-10;":[488],"Washington,":[489],"DC.":[490],"Philadelphia":[491],"(PA):":[492],"AACR;":[493],"Res":[495],"2013;73(8":[496],"Suppl):Abstract":[497],"nr":[498],"1019.":[499],"doi:10.1158/1538-7445.AM2013-1019":[500]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-06-24T00:00:00"}